<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="the PMC Open Access Subset for unrestricted research re-use and" exact="secondary" post="analysis in any form or by any means with"/>
 <result pre="(WHO) declaration of COVID-19 as a global pandemic. Abstract COVID-19" exact="infection" post="has tremendously impacted our daily clinical practice as well"/>
 <result pre="is still no evidence of higher predisposition to contract the" exact="infection" post="in patients with diabetes and/or obesity, the coexistence of"/>
 <result pre="of higher predisposition to contract the infection in patients with" exact="diabetes" post="and/or obesity, the coexistence of these conditions contributes to"/>
 <result pre="excessive mortality. Endocrine treatment modifications as a consequence of COVID-19" exact="infection" post="are required in a proactive manner, in order to"/>
 <result pre="decompensation and eventual hospital admission. This is the case of" exact="diabetes" post="and adrenal insufficiency in which prompt increase of insulin"/>
 <result pre="eventual hospital admission. This is the case of diabetes and" exact="adrenal insufficiency" post="in which prompt increase of insulin dosage and substitutive"/>
 <result pre="warrant a full study in the next future. Keywords Covid-19" exact="Diabetes mellitus" post="Obesity Malnourishment Pituitary Thyroid Calcium Vitamin D Hypoadrenalism Introduction"/>
 <result pre="full study in the next future. Keywords Covid-19 Diabetes mellitus" exact="Obesity" post="Malnourishment Pituitary Thyroid Calcium Vitamin D Hypoadrenalism Introduction Coronavirus"/>
 <result pre="in the next future. Keywords Covid-19 Diabetes mellitus Obesity Malnourishment" exact="Pituitary" post="Thyroid Calcium Vitamin D Hypoadrenalism Introduction Coronavirus disease 2019"/>
 <result pre="the next future. Keywords Covid-19 Diabetes mellitus Obesity Malnourishment Pituitary" exact="Thyroid" post="Calcium Vitamin D Hypoadrenalism Introduction Coronavirus disease 2019 (COVID-19)"/>
 <result pre="Obesity Malnourishment Pituitary Thyroid Calcium Vitamin D Hypoadrenalism Introduction Coronavirus" exact="disease" post="2019 (COVID-19) or severe acute respiratory syndrome coronavirus 2"/>
 <result pre="Vitamin D Hypoadrenalism Introduction Coronavirus disease 2019 (COVID-19) or severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak requires that endocrinologists"/>
 <result pre="D Hypoadrenalism Introduction Coronavirus disease 2019 (COVID-19) or severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2) outbreak requires that endocrinologists move"/>
 <result pre="Hypoadrenalism Introduction Coronavirus disease 2019 (COVID-19) or severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2) outbreak requires that endocrinologists move forward,"/>
 <result pre="outcomes in people affected by different endocrine diseases. People with" exact="diabetes" post="in particular, are among those in high-risk categories for"/>
 <result pre="in high-risk categories for developing serious illness modality of COVID-19" exact="infection" post="if they get the virus, but other endocrine diseases"/>
 <result pre="get the virus, but other endocrine diseases such as obesity," exact="malnutrition" post="and adrenal insufficiency may also be strongly impacted by"/>
 <result pre="virus, but other endocrine diseases such as obesity, malnutrition and" exact="adrenal insufficiency" post="may also be strongly impacted by COVID-19 [1, 2]Â"/>
 <result pre="hypothalamic-pituitary disfunction and alterations in antidiuretic hormone metabolism. 2) Thyroid:" exact="sick euthyroid syndrome;" post="3) Adrenal: probable higher susceptibility to COVID-19 in adrenal"/>
 <result pre="metabolism. 2) Thyroid: sick euthyroid syndrome; 3) Adrenal: probable higher" exact="susceptibility to" post="COVID-19 in adrenal insufficiency and Cushingâ€™s syndrome; 4) Bone."/>
 <result pre="euthyroid syndrome; 3) Adrenal: probable higher susceptibility to COVID-19 in" exact="adrenal insufficiency" post="and Cushingâ€™s syndrome; 4) Bone. Low vitamin D may"/>
 <result pre="Bone. Low vitamin D may be linked to more severe" exact="disease" post="Increased risk of hypocalcemia. 5) Testicle: Higher susceptibility and"/>
 <result pre="Low vitamin D may be linked to more severe disease" exact="Increased" post="risk of hypocalcemia. 5) Testicle: Higher susceptibility and worse"/>
 <result pre="diabetic patients; 7) Obesity. Worse prognosis in obese patients COVID-19" exact="infection" post="and diabetes mellitus Individuals with diabetes may be at"/>
 <result pre="7) Obesity. Worse prognosis in obese patients COVID-19 infection and" exact="diabetes mellitus" post="Individuals with diabetes may be at increased risk of"/>
 <result pre="in obese patients COVID-19 infection and diabetes mellitus Individuals with" exact="diabetes" post="may be at increased risk of infections, especially influenza"/>
 <result pre="especially influenza and pneumonia. This is why all people with" exact="diabetes" post="are recommended pneumococcal and annual influenza vaccinations [3]. In"/>
 <result pre="control. Data about the incidence of COVID-19 in patients with" exact="diabetes" post="are limited at present, but are increasing steadily every"/>
 <result pre="about the incidence of COVID-19 in patients with diabetes are" exact="limited" post="at present, but are increasing steadily every week; early"/>
 <result pre="but are increasing steadily every week; early reports have identified" exact="diabetes" post="and obesity as predictors of higher incidence [4â€&quot;7]. However,"/>
 <result pre="are increasing steadily every week; early reports have identified diabetes" exact="and obesity" post="as predictors of higher incidence [4â€&quot;7]. However, as population"/>
 <result pre="increasing steadily every week; early reports have identified diabetes and" exact="obesity" post="as predictors of higher incidence [4â€&quot;7]. However, as population"/>
 <result pre="countries massive COVID-19 screening has been performed, whether or not" exact="diabetes" post="is associated to a higher risk to contract COVID-19"/>
 <result pre="from hospital consultation cohorts (Fig. 2). Fig. 2 Prevalence of" exact="diabetes mellitus" post="in hospitalized COVID 19+ versus general population in different"/>
 <result pre="19+ versus general population in different countries The prevalence of" exact="diabetes" post="is higher in hospitalized patients in USA and Spain,"/>
 <result pre="have diabetes, which is not far from the prevalence of" exact="diabetes" post="in the general population in their age range in"/>
 <result pre="range in the US. Thus, confirming what was found with" exact="Influenza A (H1N1)" post="pandemic, Severe Acute Respiratory Syndrome coronavirus (SARS-CoV) and Middle"/>
 <result pre="Thus, confirming what was found with Influenza A (H1N1) pandemic," exact="Severe" post="Acute Respiratory Syndrome coronavirus (SARS-CoV) and Middle East Respiratory"/>
 <result pre="confirming what was found with Influenza A (H1N1) pandemic, Severe" exact="Acute" post="Respiratory Syndrome coronavirus (SARS-CoV) and Middle East Respiratory Syndrome"/>
 <result pre="what was found with Influenza A (H1N1) pandemic, Severe Acute" exact="Respiratory" post="Syndrome coronavirus (SARS-CoV) and Middle East Respiratory Syndrome coronavirus"/>
 <result pre="was found with Influenza A (H1N1) pandemic, Severe Acute Respiratory" exact="Syndrome" post="coronavirus (SARS-CoV) and Middle East Respiratory Syndrome coronavirus (MERS-CoV)"/>
 <result pre="pandemic, Severe Acute Respiratory Syndrome coronavirus (SARS-CoV) and Middle East" exact="Respiratory" post="Syndrome coronavirus (MERS-CoV) outbreaks, the present coronavirus epidemics does"/>
 <result pre="Severe Acute Respiratory Syndrome coronavirus (SARS-CoV) and Middle East Respiratory" exact="Syndrome" post="coronavirus (MERS-CoV) outbreaks, the present coronavirus epidemics does not"/>
 <result pre="account for a much higher capacity to infect people with" exact="diabetes" post="[9]. Increased risk of morbidity and mortality in patients"/>
 <result pre="a much higher capacity to infect people with diabetes [9]." exact="Increased" post="risk of morbidity and mortality in patients with diabetes"/>
 <result pre="[9]. Increased risk of morbidity and mortality in patients with" exact="diabetes" post="regarding COVID-19 infection Virtually all reports coincide that morbidity"/>
 <result pre="of morbidity and mortality in patients with diabetes regarding COVID-19" exact="infection" post="Virtually all reports coincide that morbidity and mortality due"/>
 <result pre="all reports coincide that morbidity and mortality due to COVID-19" exact="infection" post="are increased by the presence of diabetes. In the"/>
 <result pre="diabetes. In the series published by New York city hospitals," exact="diabetes" post="was more prevalent in those patients requiring admission (31.8%)"/>
 <result pre="in those not requiring admission (5.4%) [8] (Fig.Â 2). Indeed," exact="diabetes" post="was also reported as an important risk factor for"/>
 <result pre="was also reported as an important risk factor for worse" exact="disease" post="modality and excessive mortality while the occurrence of the"/>
 <result pre="disease modality and excessive mortality while the occurrence of the" exact="Influenza A (H1N1)" post="pandemic, SARS-CoV and MERSCoV outbreaks [4]. Influenza A (H1N1)"/>
 <result pre="the Influenza A (H1N1) pandemic, SARS-CoV and MERSCoV outbreaks [4]." exact="Influenza A (H1N1)" post="pandemic, tripled the risk of hospitalization and quadrupled the"/>
 <result pre="quadrupled the risk of intensive care unit (ICU) admission when" exact="diabetes" post="was present [3]. Consistent with that, data from China"/>
 <result pre="present [3]. Consistent with that, data from China found that" exact="diabetes" post="accounted for 8%â€&quot;16% of hospitalized patients [10, 11], being"/>
 <result pre="diabetes accounted for 8%â€&quot;16% of hospitalized patients [10, 11], being" exact="diabetes" post="prevalence across China around 5% [12]. A large report"/>
 <result pre="around 5% [12]. A large report of the Centers for" exact="Disease" post="Control and Prevention of the United States showed that"/>
 <result pre="showed that 78% of COVID-19 patients in ICUs had diabetes," exact="cardiovascular" post="diseases including hypertension or chronic lung disease [13]. A"/>
 <result pre="of COVID-19 patients in ICUs had diabetes, cardiovascular diseases including" exact="hypertension" post="or chronic lung disease [13]. A study performed by"/>
 <result pre="COVID-19 patients in ICUs had diabetes, cardiovascular diseases including hypertension" exact="or chronic" post="lung disease [13]. A study performed by the Chinese"/>
 <result pre="patients in ICUs had diabetes, cardiovascular diseases including hypertension or" exact="chronic" post="lung disease [13]. A study performed by the Chinese"/>
 <result pre="in ICUs had diabetes, cardiovascular diseases including hypertension or chronic" exact="lung disease" post="[13]. A study performed by the Chinese Centre for"/>
 <result pre="ICUs had diabetes, cardiovascular diseases including hypertension or chronic lung" exact="disease" post="[13]. A study performed by the Chinese Centre for"/>
 <result pre="disease [13]. A study performed by the Chinese Centre for" exact="Disease" post="Control and Prevention including 72,314 cases (hospital admitted and"/>
 <result pre="(1023 deaths among 44,672 confirmed cases) and in those having" exact="diabetes" post="it reached 7.3% [1]. An additional report from China"/>
 <result pre="adjusting for smoking status and age. It was found that" exact="diabetes" post="significantly increased the risk of severity according to the"/>
 <result pre="CI 1.03â€&quot;2.45); in this series, 34.6% of severe cases had" exact="diabetes" post="compared to 14.3% in non-severe cases [14]. General mortality"/>
 <result pre="cases had diabetes compared to 14.3% in non-severe cases [14]." exact="General" post="mortality rates are difficult to evaluate due to the"/>
 <result pre="the overall fatality rate was 2.3% and in people with" exact="diabetes" post="it was 7.3% [1]. Data published in Italy, indicate"/>
 <result pre="of patients who died due to COVID-19 had either diabetes," exact="cardiovascular disease" post="or cancer as comorbidities [7]. In summary, according to"/>
 <result pre="patients who died due to COVID-19 had either diabetes, cardiovascular" exact="disease" post="or cancer as comorbidities [7]. In summary, according to"/>
 <result pre="died due to COVID-19 had either diabetes, cardiovascular disease or" exact="cancer" post="as comorbidities [7]. In summary, according to current accumulated"/>
 <result pre="[7]. In summary, according to current accumulated data, persons with" exact="diabetes" post="are at increased risk for COVID-19 infection medical complications"/>
 <result pre="data, persons with diabetes are at increased risk for COVID-19" exact="infection" post="medical complications including death. Accordingly, an increased vigilance and"/>
 <result pre="death. Accordingly, an increased vigilance and testing of people with" exact="diabetes" post="in specialized outpatient and general medicine clinics for COVID-19"/>
 <result pre="Importance of glycemic control in those with coexistence of COVID-19" exact="infection" post="and diabetes To date, only a limited number of"/>
 <result pre="glycemic control in those with coexistence of COVID-19 infection and" exact="diabetes" post="To date, only a limited number of studies have"/>
 <result pre="coexistence of COVID-19 infection and diabetes To date, only a" exact="limited" post="number of studies have addressed the role of hyperglycemia"/>
 <result pre="a limited number of studies have addressed the role of" exact="hyperglycemia" post="in the pathogenesis and prognosis of viral respiratory diseases"/>
 <result pre="the role of hyperglycemia in the pathogenesis and prognosis of" exact="viral" post="respiratory diseases [1, 16]. However, it has been shown"/>
 <result pre="role of hyperglycemia in the pathogenesis and prognosis of viral" exact="respiratory" post="diseases [1, 16]. However, it has been shown that"/>
 <result pre="concentrations in airway secretion [17]. In vitro glucose exposure of" exact="pulmonary" post="epithelial cells significantly increases influenza virus infection and replication."/>
 <result pre="in airway secretion [17]. In vitro glucose exposure of pulmonary" exact="epithelial" post="cells significantly increases influenza virus infection and replication. In"/>
 <result pre="vitro glucose exposure of pulmonary epithelial cells significantly increases influenza" exact="virus infection" post="and replication. In addition, elevated glucose levels impair the"/>
 <result pre="glucose exposure of pulmonary epithelial cells significantly increases influenza virus" exact="infection" post="and replication. In addition, elevated glucose levels impair the"/>
 <result pre="impair the antiviral immune response. As a consequence, patients with" exact="diabetes" post="use to have a higher viral charge as well"/>
 <result pre="a consequence, patients with diabetes use to have a higher" exact="viral" post="charge as well as a much severe disease when"/>
 <result pre="a higher viral charge as well as a much severe" exact="disease" post="when infected with respiratory viruses. These findings are consistent"/>
 <result pre="as well as a much severe disease when infected with" exact="respiratory" post="viruses. These findings are consistent with the reports of"/>
 <result pre="with the reports of patients infected with the highly pathogenic" exact="avian influenza," post="in which hyperglycemia was associated with increased fatal outcome."/>
 <result pre="patients infected with the highly pathogenic avian influenza, in which" exact="hyperglycemia" post="was associated with increased fatal outcome. Hyperglycemia may also"/>
 <result pre="was associated with increased fatal outcome. Hyperglycemia may also affect" exact="pulmonary" post="function, and therefore, respiratory dysfunction induced by influenza virus"/>
 <result pre="fatal outcome. Hyperglycemia may also affect pulmonary function, and therefore," exact="respiratory" post="dysfunction induced by influenza virus is exacerbated in patients"/>
 <result pre="dysfunction induced by influenza virus is exacerbated in patients with" exact="diabetes" post="[18, 19]. In viral disease animal models, diabetes is"/>
 <result pre="virus is exacerbated in patients with diabetes [18, 19]. In" exact="viral" post="disease animal models, diabetes is associated with numerous lung"/>
 <result pre="is exacerbated in patients with diabetes [18, 19]. In viral" exact="disease" post="animal models, diabetes is associated with numerous lung structural"/>
 <result pre="patients with diabetes [18, 19]. In viral disease animal models," exact="diabetes" post="is associated with numerous lung structural changes, including augmented"/>
 <result pre="glycemic control can have beneficial effects in patients with coexistent" exact="diabetes" post="and viral respiratory diseases such as COVID-19. However, in"/>
 <result pre="can have beneficial effects in patients with coexistent diabetes and" exact="viral" post="respiratory diseases such as COVID-19. However, in the clinical"/>
 <result pre="have beneficial effects in patients with coexistent diabetes and viral" exact="respiratory" post="diseases such as COVID-19. However, in the clinical setting,"/>
 <result pre="in hyperglycemic patients compared to normoglycemic ones. Both, patients with" exact="hyperglycemia" post="not previously known as having diabetes and patients with"/>
 <result pre="ones. Both, patients with hyperglycemia not previously known as having" exact="diabetes" post="and patients with known diabetes had a higher risk"/>
 <result pre="not previously known as having diabetes and patients with known" exact="diabetes" post="had a higher risk of severe disease than those"/>
 <result pre="patients with known diabetes had a higher risk of severe" exact="disease" post="than those without diabetes [22]. This emphasizes the importance"/>
 <result pre="had a higher risk of severe disease than those without" exact="diabetes" post="[22]. This emphasizes the importance of early detection of"/>
 <result pre="diabetes [22]. This emphasizes the importance of early detection of" exact="hyperglycemia" post="at the hospital setting and the necessity of its"/>
 <result pre="and effective treatment with insulin [23â€&quot;25]. Treatment for people with" exact="diabetes" post="infected by COVID-19 People with diabetes who are infected"/>
 <result pre="Treatment for people with diabetes infected by COVID-19 People with" exact="diabetes" post="who are infected with COVID-19 may probably experience a"/>
 <result pre="experience a deterioration of glycemic control, like in any other" exact="infectious" post="episode. Proactive basal insulin dosage increase and correctional bolus"/>
 <result pre="is particularly hazardous to treat, because of the risk of" exact="pulmonary" post="fluid accumulation [26]. A report from a Chinese cohort"/>
 <result pre="a Chinese cohort consisting of 658 patients suggests that COVID-19" exact="infection" post="can cause ketosis per se in non-diabetic persons and"/>
 <result pre="and may increase the risk of ketoacidosis in those with" exact="diabetes" post="[27, 28]. In general, mild COVID-19 illness in people"/>
 <result pre="[27, 28]. In general, mild COVID-19 illness in people with" exact="type 2" post="diabetes on oral agents may be allowed to keep"/>
 <result pre="In general, mild COVID-19 illness in people with type 2" exact="diabetes" post="on oral agents may be allowed to keep their"/>
 <result pre="condition develops [26]. Insulin is the preferred agent to control" exact="hyperglycemia" post="in hospitalized patients, as it the most efficacious for"/>
 <result pre="as it the most efficacious for any intercurrent situation, including" exact="infections" post="[4]. Although sodium glucose cotransporter-2 inhibitors may predispose to"/>
 <result pre="has been approved in COVID-19 patients with moderate illness including" exact="respiratory" post="failure, the DARE-19 study (NCT04350593), aiming to evaluate the"/>
 <result pre="the DARE-19 study (NCT04350593), aiming to evaluate the reduction of" exact="disease" post="progression and death. Role of DPP-4 in COVID-19 as"/>
 <result pre="MERS-CoV had impaired inflammatory monocyte/macrophage phenotype, CD4+ T cells and" exact="lower" post="expression of tumor necrosis factor alpha, interleukin 6 and"/>
 <result pre="inflammatory monocyte/macrophage phenotype, CD4+ T cells and lower expression of" exact="tumor" post="necrosis factor alpha, interleukin 6 and Arg1 [31]. Remarkably,"/>
 <result pre="human DPP-4/CD26 may interact with the S1 domain of the" exact="viral" post="spike glycoprotein of SARS-CoV-2, thus allowing an additional way"/>
 <result pre="question is whether DPP-4 inhibitors used currently for treatment of" exact="type 2" post="diabetes play a role not just regarding metabolic control,"/>
 <result pre="whether DPP-4 inhibitors used currently for treatment of type 2" exact="diabetes" post="play a role not just regarding metabolic control, but"/>
 <result pre="attack in these patients, either inducing protection or progression of" exact="infection" post="(Fig.Â 3). It is tempting to postulate that inhibition"/>
 <result pre="no data are available to provide a consistent answer. COVID-19" exact="and obesity" post="Increased risk of morbidity and mortality in patients with"/>
 <result pre="data are available to provide a consistent answer. COVID-19 and" exact="obesity" post="Increased risk of morbidity and mortality in patients with"/>
 <result pre="are available to provide a consistent answer. COVID-19 and obesity" exact="Increased" post="risk of morbidity and mortality in patients with obesity"/>
 <result pre="obesity Increased risk of morbidity and mortality in patients with" exact="obesity" post="regarding COVID-19 infection Until recently, there were no specific"/>
 <result pre="of morbidity and mortality in patients with obesity regarding COVID-19" exact="infection" post="Until recently, there were no specific data in the"/>
 <result pre="no specific data in the literature reporting that subjects with" exact="obesity" post="have a higher risk of developing severe forms of"/>
 <result pre="height. However, last reports have found a strong link between" exact="obesity" post="and admission to critical care as well as the"/>
 <result pre="invasive mechanical ventilation [35]. In a study from Shenzhen (China)," exact="obesity" post="was associated with a 142% higher risk of developing"/>
 <result pre="was associated with a 142% higher risk of developing severe" exact="pneumonia" post="[36]. The Intensive Care National Audit &amp;amp; Research Centre"/>
 <result pre="Kingdom observed that 72.1% of patients with confirmed COVID-19 were" exact="overweight" post="or obese and that among patients with body mass"/>
 <result pre="In a retrospective single French center evaluating 124 consecutive patients," exact="obesity" post="(BMI &amp;gt;30Â kg/m2) and severe obesity (BMI &amp;gt;35Â kg/m2)"/>
 <result pre="evaluating 124 consecutive patients, obesity (BMI &amp;gt;30Â kg/m2) and severe" exact="obesity" post="(BMI &amp;gt;35Â kg/m2) were present in 47.6% and 28.2%"/>
 <result pre="[38]. Several reports from around the world have previously identified" exact="obesity" post="and severe obesity as risk factors for hospitalization and"/>
 <result pre="from around the world have previously identified obesity and severe" exact="obesity" post="as risk factors for hospitalization and mechanical ventilation in"/>
 <result pre="the question of whether there is a mechanistic link between" exact="obesity" post="and COVID-19 and whether obesity might independently contribute to"/>
 <result pre="is a mechanistic link between obesity and COVID-19 and whether" exact="obesity" post="might independently contribute to COVID-19 risk or at least"/>
 <result pre="least to more severe forms of the disease. How can" exact="obesity" post="impact COVID-19 infection? The high impact of H1N1 Influenza"/>
 <result pre="How can obesity impact COVID-19 infection? The high impact of" exact="H1N1 Influenza" post="and now COVID-19 in patients with obesity and severe"/>
 <result pre="impact of H1N1 Influenza and now COVID-19 in patients with" exact="obesity" post="and severe obesity is probably related to the deleterious"/>
 <result pre="Influenza and now COVID-19 in patients with obesity and severe" exact="obesity" post="is probably related to the deleterious effects of obesity"/>
 <result pre="severe obesity is probably related to the deleterious effects of" exact="obesity" post="on pulmonary function (Fig.Â 4). Obesity is associated with"/>
 <result pre="is probably related to the deleterious effects of obesity on" exact="pulmonary" post="function (Fig.Â 4). Obesity is associated with decreased expiratory"/>
 <result pre="the deleterious effects of obesity on pulmonary function (Fig.Â 4)." exact="Obesity" post="is associated with decreased expiratory reserve volume, functional capacity"/>
 <result pre="is associated with decreased expiratory reserve volume, functional capacity and" exact="respiratory" post="system compliance. Severe obesity causes sleep apnea syndrome and"/>
 <result pre="decreased expiratory reserve volume, functional capacity and respiratory system compliance." exact="Severe obesity" post="causes sleep apnea syndrome and in those with increased"/>
 <result pre="expiratory reserve volume, functional capacity and respiratory system compliance. Severe" exact="obesity" post="causes sleep apnea syndrome and in those with increased"/>
 <result pre="volume, functional capacity and respiratory system compliance. Severe obesity causes" exact="sleep apnea" post="syndrome and in those with increased abdominal obesity, pulmonary"/>
 <result pre="capacity and respiratory system compliance. Severe obesity causes sleep apnea" exact="syndrome" post="and in those with increased abdominal obesity, pulmonary function"/>
 <result pre="sleep apnea syndrome and in those with increased abdominal obesity," exact="pulmonary" post="function is further impaired by decreased diaphragmatic excursion. Fig."/>
 <result pre="by decreased diaphragmatic excursion. Fig. 4 Potential mechanisms that link" exact="obesity" post="to worse outcomes in COVID-19. Obese patients have 1)"/>
 <result pre="worse outcomes in COVID-19. Obese patients have 1) a impaired" exact="respiratory" post="function; 2) associated cardiovascular, metabolic and thrombotic comorbidities which"/>
 <result pre="cope with COVID-19. In addition, obese patients have 3) increased" exact="viral" post="shedding and viral load and 4) an amplified immune"/>
 <result pre="In addition, obese patients have 3) increased viral shedding and" exact="viral" post="load and 4) an amplified immune response due to"/>
 <result pre="to altered balance between inflammatory and regulatory cells. During COVID-19" exact="infection" post="there is also an altered immune response that is"/>
 <result pre="the dysregulated immune system of the obese patients In addition," exact="obesity" post="contributes to increase the risk of different comorbidities including"/>
 <result pre="contributes to increase the risk of different comorbidities including diabetes," exact="cardiovascular" post="risk and thrombosis, which may have a great impact"/>
 <result pre="great impact in COVID-19 infected patients outcomes, thus confirming that" exact="obesity" post="rises the severity of COVID-19 infection [10, 40]. In"/>
 <result pre="outcomes, thus confirming that obesity rises the severity of COVID-19" exact="infection" post="[10, 40]. In addition, obesity could increase per se,"/>
 <result pre="rises the severity of COVID-19 infection [10, 40]. In addition," exact="obesity" post="could increase per se, the risk of different comorbidities"/>
 <result pre="increase per se, the risk of different comorbidities including diabetes," exact="cardiovascular" post="risk and thrombosis in COVID-19, which can intensify the"/>
 <result pre="the risk of different comorbidities including diabetes, cardiovascular risk and" exact="thrombosis" post="in COVID-19, which can intensify the severity of COVID"/>
 <result pre="to the immune response, there is a clear association between" exact="obesity" post="and chronic inflammation that can modify innate and adaptive"/>
 <result pre="immune response, there is a clear association between obesity and" exact="chronic" post="inflammation that can modify innate and adaptive immune responses,"/>
 <result pre="adaptive immune responses, making the immune system more vulnerable to" exact="infections" post="[41]. Obesity is related to low-grade inflammation that is"/>
 <result pre="responses, making the immune system more vulnerable to infections [41]." exact="Obesity" post="is related to low-grade inflammation that is associated to"/>
 <result pre="is related to low-grade inflammation that is associated to adipocyte" exact="hypoxia" post="and dysfunction. This results in an exuberant secretion of"/>
 <result pre="results in an exuberant secretion of pro-inflammatory cytokines such as" exact="tumor" post="necrosis factor Î± (TNF- Î±), interleukin (IL) 1Î² and"/>
 <result pre="and Th2 cells and an increase in Th1 an Th17." exact="Viral" post="infection may amplify the already primed organ cytokine response"/>
 <result pre="Th2 cells and an increase in Th1 an Th17. Viral" exact="infection" post="may amplify the already primed organ cytokine response in"/>
 <result pre="one of the most important mechanisms underlying the severity of" exact="lung disease" post="in COVID-19 is represented by the so called â€œcytokine"/>
 <result pre="of the most important mechanisms underlying the severity of lung" exact="disease" post="in COVID-19 is represented by the so called â€œcytokine"/>
 <result pre="by the so called â€œcytokine stormâ€�, which can lead to" exact="acute" post="respiratory distress syndrome or even multiple organ failure in"/>
 <result pre="the so called â€œcytokine stormâ€�, which can lead to acute" exact="respiratory" post="distress syndrome or even multiple organ failure in the"/>
 <result pre="called â€œcytokine stormâ€�, which can lead to acute respiratory distress" exact="syndrome" post="or even multiple organ failure in the worst case."/>
 <result pre="in the worst case. The cytokine storm identified in multiple" exact="respiratory" post="viral infections including COVID-19 exhibits an overproduction of interferon,"/>
 <result pre="the worst case. The cytokine storm identified in multiple respiratory" exact="viral" post="infections including COVID-19 exhibits an overproduction of interferon, tumor"/>
 <result pre="worst case. The cytokine storm identified in multiple respiratory viral" exact="infections" post="including COVID-19 exhibits an overproduction of interferon, tumor necrosis"/>
 <result pre="respiratory viral infections including COVID-19 exhibits an overproduction of interferon," exact="tumor" post="necrosis factor Î±, interleukins, and different chemokines. Thus, considering"/>
 <result pre="Î±, interleukins, and different chemokines. Thus, considering that subjects with" exact="obesity" post="have also a pre-set proinflammatory milieu, it is expected"/>
 <result pre="increased risk of severe complications of COVID-19 in subjects with" exact="obesity" post="[43]. Obese individuals may exhibit greater viral shedding suggesting"/>
 <result pre="in subjects with obesity [43]. Obese individuals may exhibit greater" exact="viral" post="shedding suggesting potential for enhanced viral exposure, especially if"/>
 <result pre="individuals may exhibit greater viral shedding suggesting potential for enhanced" exact="viral" post="exposure, especially if several family members are overweight. This"/>
 <result pre="are more common in the socioeconomically deprived communities in which" exact="obesity" post="is prevalent [44]. In addition, in influenza infection obesity"/>
 <result pre="in which obesity is prevalent [44]. In addition, in influenza" exact="infection" post="obesity not only increases the severity but also enhances"/>
 <result pre="which obesity is prevalent [44]. In addition, in influenza infection" exact="obesity" post="not only increases the severity but also enhances viral"/>
 <result pre="infection obesity not only increases the severity but also enhances" exact="viral" post="diversity. The altered microenvironment associated with obesity supports the"/>
 <result pre="but also enhances viral diversity. The altered microenvironment associated with" exact="obesity" post="supports the emergence of more virulent influenza virus population"/>
 <result pre="of more virulent influenza virus population capable of inducing greater" exact="disease" post="severity. This could be related to an impaired interferon"/>
 <result pre="experimental models, both in obese mice and obesity-derived human bronchial" exact="epithelial" post="cells [45]. The same could happen in COVID-19 infection."/>
 <result pre="The same could happen in COVID-19 infection. Finally, subjects with" exact="obesity" post="have also mechanical issues related to excessive weight that"/>
 <result pre="to excessive weight that make difficult an early diagnosis with" exact="pulmonary" post="ultrasound and other imaging techniques, thus leading to a"/>
 <result pre="a slowdown in therapeutic steps, worsening prognosis in patients with" exact="obesity" post="and COVID-19 [46]. Recommendations for people with obesity regarding"/>
 <result pre="patients with obesity and COVID-19 [46]. Recommendations for people with" exact="obesity" post="regarding COVID-19 infection There is a need for increased"/>
 <result pre="and COVID-19 [46]. Recommendations for people with obesity regarding COVID-19" exact="infection" post="There is a need for increased vigilance, priority on"/>
 <result pre="as well as a proactive therapy policy for patients with" exact="obesity" post="and COVID-19 infections. The assessment of metabolic phenotype is"/>
 <result pre="might not be forgotten to be done, both, in the" exact="primary" post="care setting as well as in the hospital setting"/>
 <result pre="prevent severe health consequences, but the risk of severe COVID-19" exact="infection" post="might now be another important reason to focus on"/>
 <result pre="another important reason to focus on these issues. Persons with" exact="obesity" post="who become COVID-19 ill and require treatment in intensive"/>
 <result pre="up enough to manage an increasing number of patients with" exact="obesity" post="in ICUs and the current crisis could probably highlight"/>
 <result pre="Nutrition &amp;amp; vitamin D and COVID-19 Regarding undernourished subjects, COVID-19" exact="infection" post="is associated to a high risk of malnutrition development,"/>
 <result pre="subjects, COVID-19 infection is associated to a high risk of" exact="malnutrition" post="development, mostly related to augmenting requirements and the presence"/>
 <result pre="related to augmenting requirements and the presence of a severe" exact="acute" post="inflammatory status. These patients show also a hyporexic state,"/>
 <result pre="patients show also a hyporexic state, thus contributing to an" exact="acute" post="negative nutritional balance. Estimated nutritional requirements for these patients"/>
 <result pre="nutritional requirements are not met during hospital stay, complementary or" exact="complete" post="enteral feeding may be required and, in case that"/>
 <result pre="expected to improve with an adequate nutritional support. Vitamin D" exact="deficiency" post="is widespread in Southern Europe where vitamin D fortified"/>
 <result pre="Vitamin D insufficiency has been reported to increase predisposition to" exact="systemic" post="infections and to impair immune response or even to"/>
 <result pre="D insufficiency has been reported to increase predisposition to systemic" exact="infections" post="and to impair immune response or even to enhance"/>
 <result pre="impair immune response or even to enhance the development of" exact="autoimmune diseases" post="[49]. Moreover, it has been shown that vitamin D"/>
 <result pre="it has been shown that vitamin D supplementation can prevent" exact="respiratory" post="infections [50] and poor vitamin D status may aggravate"/>
 <result pre="has been shown that vitamin D supplementation can prevent respiratory" exact="infections" post="[50] and poor vitamin D status may aggravate the"/>
 <result pre="that hypovitaminosis D may be a predisposing factor to COVID-19" exact="infection" post="and aggressiveness in some European countries [52], we strongly"/>
 <result pre="has been previously associated with lipid abnormalities, including elevations of" exact="total" post="cholesterol and triglycerides [59]. Chronic use of tocilizumab in"/>
 <result pre="lipid abnormalities, including elevations of total cholesterol and triglycerides [59]." exact="Chronic" post="use of tocilizumab in rheumatoid arthritis has also been"/>
 <result pre="total cholesterol and triglycerides [59]. Chronic use of tocilizumab in" exact="rheumatoid arthritis" post="has also been shown to increase lipid parameters, in"/>
 <result pre="cholesterol and triglycerides [59]. Chronic use of tocilizumab in rheumatoid" exact="arthritis" post="has also been shown to increase lipid parameters, in"/>
 <result pre="studies have reported the effectiveness of statin treatment in some" exact="viral" post="infections including reducing influenza-related hospitalizations and deaths [63]. As"/>
 <result pre="have reported the effectiveness of statin treatment in some viral" exact="infections" post="including reducing influenza-related hospitalizations and deaths [63]. As statins"/>
 <result pre="were evaluated after recovery: 40% had evidence of central mild" exact="hypocortisolism" post="and 5% also had central hypothyroidism [64]. Edema and"/>
 <result pre="evidence of central mild hypocortisolism and 5% also had central" exact="hypothyroidism" post="[64]. Edema and neuronal degeneration along with SARS-CoV genome"/>
 <result pre="central mild hypocortisolism and 5% also had central hypothyroidism [64]." exact="Edema" post="and neuronal degeneration along with SARS-CoV genome have been"/>
 <result pre="hypocortisolism and 5% also had central hypothyroidism [64]. Edema and" exact="neuronal" post="degeneration along with SARS-CoV genome have been identified in"/>
 <result pre="hypothalamic and pituitary tissues express ACE2 and could also be" exact="viral" post="targets [65]. Currently, we do not have any such"/>
 <result pre="hypophysitis [66]. Recommendations for people with pituitary disorders regarding COVID-19" exact="infection" post="Management of pituitary tumors without mass effects and without"/>
 <result pre="In the case of pituitary tumors (except prolactinomas) with severe" exact="visual" post="deterioration, surgery is the treatment of choice, with previous"/>
 <result pre="higher prevalence of dysnatremia in COVID-19 [69]. Regarding management of" exact="diabetes insipidus," post="since patients have limited accessibility to blood testing, the"/>
 <result pre="COVID-19 [69]. Regarding management of diabetes insipidus, since patients have" exact="limited" post="accessibility to blood testing, the priority should be to"/>
 <result pre="accessibility to blood testing, the priority should be to avoid" exact="hyponatremia" post="[70]. This can be performed delaying desmopressin to allow"/>
 <result pre="useful to measure body weight daily. In addition, patients with" exact="diabetes insipidus" post="who develop respiratory complications of COVID-19 are at significantly"/>
 <result pre="weight daily. In addition, patients with diabetes insipidus who develop" exact="respiratory" post="complications of COVID-19 are at significantly increased risk of"/>
 <result pre="2003 had reported that serum Triiodothyronine and thyroxine levels were" exact="lower" post="in patients with SARS as compared to controls, both"/>
 <result pre="patients with SARS as compared to controls, both during the" exact="acute" post="and convalescent phases. This could simply imply an underlying"/>
 <result pre="acute and convalescent phases. This could simply imply an underlying" exact="euthyroid sick syndrome." post="However, a study of the autopsy in five patients"/>
 <result pre="and not a reduction in thyroid follicular size associated with" exact="euthyroid sick syndrome" post="[72]. Destruction of follicular cells may also be identified"/>
 <result pre="a reduction in thyroid follicular size associated with euthyroid sick" exact="syndrome" post="[72]. Destruction of follicular cells may also be identified"/>
 <result pre="be a precipitating factor for initiation or relapse of the" exact="disease" post="(M. Marazuela, personal experience). Several medical societies have recommended"/>
 <result pre="societies have recommended to take special care to patients with" exact="hyperthyroidism" post="receiving antithyroid drugs, because symptoms of the rare side"/>
 <result pre="antithyroid drugs, because symptoms of the rare side effect of" exact="agranulocytosis" post="can overlap with COVID-19. In this scenario, if symptoms"/>
 <result pre="overlap with COVID-19. In this scenario, if symptoms of COVID-19," exact="agranulocytosis" post="should be ruled out immediately with a full blood"/>
 <result pre="of thyroid nodules as well as thyroid surgery for either" exact="benign" post="or malignant thyroid nodules for differentiated thyroid cancers have"/>
 <result pre="nodules as well as thyroid surgery for either benign or" exact="malignant" post="thyroid nodules for differentiated thyroid cancers have been generally"/>
 <result pre="1 out of 12 patients who received radioiodine for differentiated" exact="thyroid carcinoma" post="also showed interstitial pneumonia on single photon emission computed"/>
 <result pre="out of 12 patients who received radioiodine for differentiated thyroid" exact="carcinoma" post="also showed interstitial pneumonia on single photon emission computed"/>
 <result pre="who received radioiodine for differentiated thyroid carcinoma also showed interstitial" exact="pneumonia" post="on single photon emission computed tomography [74]. The adrenal"/>
 <result pre="single photon emission computed tomography [74]. The adrenal and COVID-19" exact="Adrenal insufficiency" post="Life-long replacement treatment aiming to mimic physiologic plasma cortisol"/>
 <result pre="plasma cortisol concentrations is not easy to be achieved in" exact="adrenal insufficiency" post="patients. Many circumstances, either organic and/or psychological, might unbalance"/>
 <result pre="may be a new reason for patient and physician concern." exact="Adrenal insufficiency" post="may confer a potentially increased risk of acquiring COVID-19"/>
 <result pre="This may explain, in part, the slightly increased rate of" exact="infectious diseases" post="in these patients, as well as an overall higher"/>
 <result pre="as well as an overall higher mortality. Although patients with" exact="adrenal insufficiency" post="may have a greater risk of complications due to"/>
 <result pre="greater risk of complications due to the potential for an" exact="adrenal crisis" post="to be triggered by the infection, there is still"/>
 <result pre="died from SARS-CoV showed degeneration and necrosis of the adrenal" exact="cortical" post="cells, pointing to a direct cytopathic effect of the"/>
 <result pre="blunt the stress-induced cortisol rise, as antibodies produced against the" exact="viral" post="particles will inadvertently destroy the circulating ACTH [77]. However,"/>
 <result pre="this same strategy. The increase in morbidity and mortality in" exact="adrenal insufficiency" post="could also be accounted by an insufficient compensatory self-adjusted"/>
 <result pre="information, patients with AI should observe stringent social distancing. Cushingâ€™s" exact="syndrome" post="Patients with Cushingâ€™s disease, but particularly those under supraphysiologic"/>
 <result pre="[79] may be also at a higher risk of COVID-19" exact="infection" post="because of the steroids potential immunosuppressive action. This issue"/>
 <result pre="important, as around 5% of the worldâ€™s population is taking" exact="chronic" post="corticosteroids and there is a high prevalence of AI"/>
 <result pre="be recommendable to follow the same rules as patients with" exact="adrenal insufficiency." post="Regarding diagnosis and therapy of patients with endogenous Cushingâ€™s"/>
 <result pre="cortisol/cortisone tests should be avoided due to the potential of" exact="viral" post="contamination and infection of laboratory staff. Treatment of potential"/>
 <result pre="be avoided due to the potential of viral contamination and" exact="infection" post="of laboratory staff. Treatment of potential co-morbidities (such as"/>
 <result pre="infection of laboratory staff. Treatment of potential co-morbidities (such as" exact="hypertension" post="and diabetes) should be optimized and medical treatment must"/>
 <result pre="glucocorticoid) in order to ease the monitoring [81]. Calcium &amp;amp;" exact="Hypoparathyroidism" post="and COVID-19 Several studies showed a key role of"/>
 <result pre="COVID-19 Several studies showed a key role of calcium in" exact="viral" post="fusion for many enveloped viruses such as SARS-CoV, MERS-CoV"/>
 <result pre="replication directly interacting with fusion peptides of these viruses [82â€&quot;84]." exact="Hypocalcemia" post="had already shown to be common in patients with"/>
 <result pre="although generally mild [85], and in patients with Ebola virus" exact="disease" post="(62%) [86]. A case of COVID-19 infection has been"/>
 <result pre="with Ebola virus disease (62%) [86]. A case of COVID-19" exact="infection" post="has been recently reported as possible precipitating cause of"/>
 <result pre="been recently reported as possible precipitating cause of subclinical postsurgical" exact="hypoparathyroidism" post="presenting with severe hypocalcemia [87]. This case suggested that"/>
 <result pre="possible precipitating cause of subclinical postsurgical hypoparathyroidism presenting with severe" exact="hypocalcemia" post="[87]. This case suggested that hypocalcemia may occur also"/>
 <result pre="hypoparathyroidism presenting with severe hypocalcemia [87]. This case suggested that" exact="hypocalcemia" post="may occur also in COVID-19 infection. In fact, very"/>
 <result pre="study including 531 patients with COVID-19 a high prevalence of" exact="hypocalcemia" post="(in about 80% of cases) on initial hospital evaluation."/>
 <result pre="calcium levels and LDH and PCR levels. In multivariate analyses," exact="hypocalcemia" post="was an independent risk factor associated with hospitalization whereas"/>
 <result pre="mortality only in univariate analysis. [88].Therefore, all patients with postsurgical" exact="hypoparathyroidism" post="should continue their treatment to avoid severe acute hypocalcemia,"/>
 <result pre="with postsurgical hypoparathyroidism should continue their treatment to avoid severe" exact="acute" post="hypocalcemia, which can be life-threatening, and eventually should be"/>
 <result pre="be adequately treated [89]. Moreover, mild hypoparathyroid patients not requiring" exact="chronic" post="treatment should undergo careful surveillance in areas hit by"/>
 <result pre="outbreak of COVID-19 outbreaks, particularly if overweight/obese [90]. Finally, since" exact="hypocalcemia" post="may have negative impact on cardiac outcomesÂ [87], calcium"/>
 <result pre="adequate supplementation if needed in all hospitalized patients with COVID-19" exact="infection" post="is recommended. Androgens and COVID-19 Evaluation of the gender-related"/>
 <result pre="the gender-related distribution has revealed that men had a higher" exact="susceptibility to" post="the virus infection and worse clinical outcomes and COVID-19"/>
 <result pre="has revealed that men had a higher susceptibility to the" exact="virus infection" post="and worse clinical outcomes and COVID-19 deaths compared with"/>
 <result pre="revealed that men had a higher susceptibility to the virus" exact="infection" post="and worse clinical outcomes and COVID-19 deaths compared with"/>
 <result pre="These gender differences were observed among all age groups of" exact="adult" post="patients [10, 91]. A possible mechanism that may drive"/>
 <result pre="cytokine storm and lead to an improved survival rate. SARS-CoV-2" exact="viral" post="entry requires two host proteins [93]: the angiotensin converting"/>
 <result pre="[94] and TMPRSS2 is the most frequently altered gene in" exact="primary" post="prostate cancer [95]. The modulation of TMPRSS2 expression by"/>
 <result pre="and TMPRSS2 is the most frequently altered gene in primary" exact="prostate cancer" post="[95]. The modulation of TMPRSS2 expression by testosterone has"/>
 <result pre="TMPRSS2 is the most frequently altered gene in primary prostate" exact="cancer" post="[95]. The modulation of TMPRSS2 expression by testosterone has"/>
 <result pre="has been postulated to contribute to male predominance of COVID-19" exact="infection" post="[96]. Since TMPRSS2 is expressed also at pulmonary level,"/>
 <result pre="of COVID-19 infection [96]. Since TMPRSS2 is expressed also at" exact="pulmonary" post="level, the use of TMPRSS2 inhibitors, currently being used"/>
 <result pre="level, the use of TMPRSS2 inhibitors, currently being used for" exact="prostate cancer," post="represents an appealing target for prevention or treatment for"/>
 <result pre="represents an appealing target for prevention or treatment for COVID-19" exact="pneumonia" post="[93]. Adverse outcomes of COVID-19 in men could also"/>
 <result pre="be associated to a higher prevalence of comorbidities, including hypertension," exact="cardiovascular disease," post="and lung disease. Ongoing COVID-19 research involving endocrine targets"/>
 <result pre="a higher prevalence of comorbidities, including hypertension, cardiovascular disease, and" exact="lung disease." post="Ongoing COVID-19 research involving endocrine targets Role of ACE2"/>
 <result pre="to the zinc peptidase ACE2, a surface molecule that is" exact="localized" post="in the endothelial cells of arteries and veins, arterial"/>
 <result pre="the endothelial cells of arteries and veins, arterial smooth muscle," exact="respiratory" post="tract epithelium, epithelia of the small intestine, and immune"/>
 <result pre="[97]. With SARS-CoV, it was shown that ACE2 overexpression facilitated" exact="viral" post="entry and replication in cells [98]. SARS-CoV-2 probably targets"/>
 <result pre="cells targeted by SARS-CoV, which in the lungs are primarily" exact="localized" post="in pneumocytes and macrophages [93]. Acute respiratory distress syndrome"/>
 <result pre="the lungs are primarily localized in pneumocytes and macrophages [93]." exact="Acute respiratory distress syndrome" post="(ARDS), which is the most serious complication of both"/>
 <result pre="lungs are primarily localized in pneumocytes and macrophages [93]. Acute" exact="respiratory" post="distress syndrome (ARDS), which is the most serious complication"/>
 <result pre="primarily localized in pneumocytes and macrophages [93]. Acute respiratory distress" exact="syndrome" post="(ARDS), which is the most serious complication of both"/>
 <result pre="extrapulmonary manifestations of COVID-19 may also be related to the" exact="systemic" post="distribution of ACE2 in the gastrointestinal tract and the"/>
 <result pre="systemic distribution of ACE2 in the gastrointestinal tract and the" exact="heart" post="[15, 99]. There is evidence that ACE2 expression increases"/>
 <result pre="virus into the host cell and increase the chances of" exact="infection" post="or its severity [101]. Unfortunately, data if ACE inhibitors"/>
 <result pre="and/or angiotensin-receptor blockers, when infected, is beneficial with regard to" exact="pulmonary" post="outcome. Possibly, we are dealing here with a double-edged"/>
 <result pre="preferentially using renin-angiotensin system blockade and ACE2 replacement in the" exact="acute" post="respiratory syndrome phase may turn out to be beneficial"/>
 <result pre="using renin-angiotensin system blockade and ACE2 replacement in the acute" exact="respiratory" post="syndrome phase may turn out to be beneficial [103,"/>
 <result pre="renin-angiotensin system blockade and ACE2 replacement in the acute respiratory" exact="syndrome" post="phase may turn out to be beneficial [103, 104]."/>
 <result pre="angiotensin aldosterone antagonists in high-risk patients, including those who have" exact="heart" post="failure or have had myocardial infarction, may result in"/>
 <result pre="patients, including those who have heart failure or have had" exact="myocardial infarction," post="may result in clinical instability and adverse health outcomes."/>
 <result pre="this regard, the European Society of Cardiology, Council on Hypertension;" exact="American" post="College of Cardiology, the American Heart Association and the"/>
 <result pre="of Cardiology, Council on Hypertension; American College of Cardiology, the" exact="American" post="Heart Association and the Heart Failure Society of America"/>
 <result pre="Cardiology, Council on Hypertension; American College of Cardiology, the American" exact="Heart" post="Association and the Heart Failure Society of America and"/>
 <result pre="American College of Cardiology, the American Heart Association and the" exact="Heart Failure" post="Society of America and the American Society of hypertension"/>
 <result pre="College of Cardiology, the American Heart Association and the Heart" exact="Failure" post="Society of America and the American Society of hypertension"/>
 <result pre="Association and the Heart Failure Society of America and the" exact="American" post="Society of hypertension have released policy statements strongly recommending"/>
 <result pre="Heart Failure Society of America and the American Society of" exact="hypertension" post="have released policy statements strongly recommending that patients should"/>
 <result pre="angiotensin receptor blockers should be discontinued because of the COVID-19" exact="infection" post="[103, 105]. Use of oxytocin in COVID [106] Oxytocin"/>
 <result pre="the innate immunity. In humans, in the early phases of" exact="infectious disease," post="oxytocin can limit the excessive proinflammatory and oxidative stress"/>
 <result pre="key signaling molecule acting as a host response modulator in" exact="viral" post="infections. In humans, activation of the oxytocin receptor, which"/>
 <result pre="activation of the oxytocin receptor, which is expressed in the" exact="pulmonary" post="artery, can produce a vasolidatory effect [107]. Oxytocin has"/>
 <result pre="and melatonin, a well-known anti-inflammatory and anti-oxidative molecule, protects against" exact="acute" post="respiratory distress syndrome caused by viral and other pathogens."/>
 <result pre="melatonin, a well-known anti-inflammatory and anti-oxidative molecule, protects against acute" exact="respiratory" post="distress syndrome caused by viral and other pathogens. Melatonin"/>
 <result pre="well-known anti-inflammatory and anti-oxidative molecule, protects against acute respiratory distress" exact="syndrome" post="caused by viral and other pathogens. Melatonin is effective"/>
 <result pre="anti-oxidative molecule, protects against acute respiratory distress syndrome caused by" exact="viral" post="and other pathogens. Melatonin is effective in critical care"/>
 <result pre="patients. In addition, melatonin could be an adjuvant to prevent" exact="pulmonary" post="fibrosis [108]. Notably, melatonin has a high safety profile"/>
 <result pre="References References 1.WuZMcGooganJMCharacteristics of and important lessons from the coronavirus" exact="disease" post="2019 (COVID-19) outbreak in China: summary of a report"/>
 <result pre="report of 72 314 cases from the Chinese Center for" exact="Disease" post="Control and PreventionJAMA.20203231239 2.DengS-QPengH-JCharacteristics of and public health responses"/>
 <result pre="PreventionJAMA.20203231239 2.DengS-QPengH-JCharacteristics of and public health responses to the coronavirus" exact="disease" post="2019 outbreak in ChinaJ Clin Med20209575 3.AlvesCCasqueiroJCasqueiroJInfections in patients"/>
 <result pre="2019 outbreak in ChinaJ Clin Med20209575 3.AlvesCCasqueiroJCasqueiroJInfections in patients with" exact="diabetes" post="mellitus: a review of pathogenesisIndian J Endocrinol Metab20121627 4.GuptaRGhoshASinghAKMisraAClinical"/>
 <result pre="of pathogenesisIndian J Endocrinol Metab20121627 4.GuptaRGhoshASinghAKMisraAClinical considerations for patients with" exact="diabetes" post="in times of COVID-19 epidemicDiabetes Metab Syndr20201421121232172175 5.ZhangJDongXCaoYYuanYYangYYanYet al.Clinical"/>
 <result pre="Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel coronavirus-infected" exact="pneumonia" post="in Wuhan, China JAMA 2020; 7.Remuzzi A, Remuzzi G."/>
 <result pre="with hospitalization and critical illness among 4,103 patients with COVID-19" exact="disease" post="in New York City [internet]. Intensive care and critical"/>
 <result pre="medicine; 2020 Apr. Available from:. http://medrxiv.org/lookup/doi/10.1101/2020.04.08.20057794. 9.FadiniGPMorieriMLLongatoEAvogaroAPrevalence and impact of" exact="diabetes" post="among people infected with SARS-CoV-2J Endocrinol Investig20204386786932222956 10.Guan W,"/>
 <result pre="Ou C, He J, et al. Clinical Characteristics of Coronavirus" exact="Disease" post="2019 in China. N Engl J Med. 2020;NEJMoa2002032. 11.LiBYangJZhaoFZhiLWangXLiuLBiZZhaoYPrevalence"/>
 <result pre="China. N Engl J Med. 2020;NEJMoa2002032. 11.LiBYangJZhaoFZhiLWangXLiuLBiZZhaoYPrevalence and impact of" exact="cardiovascular" post="metabolic diseases on COVID-19 in ChinaClin Res Cardiol Off"/>
 <result pre="N Engl J Med. 2020;NEJMoa2002032. 11.LiBYangJZhaoFZhiLWangXLiuLBiZZhaoYPrevalence and impact of cardiovascular" exact="metabolic diseases" post="on COVID-19 in ChinaClin Res Cardiol Off J Ger"/>
 <result pre="review of clinical data in ChinaMech Ageing Dev202018811125532353398 13.Center for" exact="Disease" post="Control and Prevention. Interim Clinical Guidance for Management of"/>
 <result pre="Interim Clinical Guidance for Management of Patients with Confirmed Coronavirus" exact="Disease" post="(COVID-19). [Internet]. Httpswwwcdcgovcoronavirus2019-Ncovhcpclinical-Guid.-Manag.-Patientshtml. 2020 [cited 2020 Apr 3]. Available"/>
 <result pre="ThanhLKamelMGGhazyAAAltibiAMADatLMet al.Clinical outcomes of current medical approaches for Middle East" exact="respiratory" post="syndrome: a systematic review and meta-analysisRev Med Virol201828e197729664167 18.LÃ³pez-CanoCLecubeAGarcÃ­a-RamÃ­rezMMuÃ±ozXSÃ¡nchezESeminarioAHernÃ¡ndezMCiudinAGutiÃ©rrezLHernÃ¡ndezCSimÃ³RSerum"/>
 <result pre="a biomarker for measuring lung involvement in obese patients with" exact="type 2" post="diabetesJ Clin Endocrinol Metab20171024109411628945872 19.LecubeASimÃ³RPallayovaMPunjabiNMLÃ³pez-CanoCTurinoCHernÃ¡ndezCBarbÃ©FPulmonary function and sleep breathing:"/>
 <result pre="Metab20171024109411628945872 19.LecubeASimÃ³RPallayovaMPunjabiNMLÃ³pez-CanoCTurinoCHernÃ¡ndezCBarbÃ©FPulmonary function and sleep breathing: two new targets for" exact="type 2" post="diabetes careEndocr Rev20173855057328938479 20.PhilipsBJMeguerJ-XRedmanJBakerEHFactors determining the appearance of glucose"/>
 <result pre="function and sleep breathing: two new targets for type 2" exact="diabetes" post="careEndocr Rev20173855057328938479 20.PhilipsBJMeguerJ-XRedmanJBakerEHFactors determining the appearance of glucose in"/>
 <result pre="diabetes careEndocr Rev20173855057328938479 20.PhilipsBJMeguerJ-XRedmanJBakerEHFactors determining the appearance of glucose in" exact="upper" post="and lower respiratory tract secretionsIntensive Care Med2003292204221014647890 21.ZhouJTanJDiabetes patients"/>
 <result pre="Rev20173855057328938479 20.PhilipsBJMeguerJ-XRedmanJBakerEHFactors determining the appearance of glucose in upper and" exact="lower" post="respiratory tract secretionsIntensive Care Med2003292204221014647890 21.ZhouJTanJDiabetes patients with COVID-19"/>
 <result pre="20.PhilipsBJMeguerJ-XRedmanJBakerEHFactors determining the appearance of glucose in upper and lower" exact="respiratory" post="tract secretionsIntensive Care Med2003292204221014647890 21.ZhouJTanJDiabetes patients with COVID-19 need"/>
 <result pre="Affected by Covid-19: Can We Do More on Glycemic Control?" exact="Diabetes" post="Care. 2020:dc200723. 23.Lucas MartÃ­nAMGuanyabensEZavala-AraucoRChamorroJGranadaMLMauricioDPuig-DomingoMBreaking therapeutic inertia in type 2"/>
 <result pre="Glycemic Control? Diabetes Care. 2020:dc200723. 23.Lucas MartÃ­nAMGuanyabensEZavala-AraucoRChamorroJGranadaMLMauricioDPuig-DomingoMBreaking therapeutic inertia in" exact="type 2" post="diabetes: active detection of in-patient cases allows improvement of"/>
 <result pre="X, Chen J, Zuo X, Zhang H, Deng A. COVID-19" exact="infection" post="may cause ketosis and ketoacidosis. Diabetes Obes Metab. 2020."/>
 <result pre="H, Deng A. COVID-19 infection may cause ketosis and ketoacidosis." exact="Diabetes" post="Obes Metab. 2020. 28.BornsteinSRRubinoFKhuntiKMingroneGHopkinsDBirkenfeldALBoehmBAmielSHoltRIGSkylerJSDeVriesJHRenardEEckelRHZimmetPAlbertiKGVidalJGelonezeBChanJCJiLLudwigBPractical recommendations for the management of"/>
 <result pre="Diabetes Obes Metab. 2020. 28.BornsteinSRRubinoFKhuntiKMingroneGHopkinsDBirkenfeldALBoehmBAmielSHoltRIGSkylerJSDeVriesJHRenardEEckelRHZimmetPAlbertiKGVidalJGelonezeBChanJCJiLLudwigBPractical recommendations for the management of" exact="diabetes" post="in patients with COVID-19Lancet Diabetes Endocrinol2020854655032334646 29.RajVSMouHSmitsSLDekkersDHWMÃ¼llerMADijkmanRMuthDDemmersJAAZakiAFouchierRAMThielVDrostenCRottierPJMOsterhausADMEBoschBJHaagmansBLDipeptidyl peptidase 4"/>
 <result pre="recommendations for the management of diabetes in patients with COVID-19Lancet" exact="Diabetes" post="Endocrinol2020854655032334646 29.RajVSMouHSmitsSLDekkersDHWMÃ¼llerMADijkmanRMuthDDemmersJAAZakiAFouchierRAMThielVDrostenCRottierPJMOsterhausADMEBoschBJHaagmansBLDipeptidyl peptidase 4 is a functional receptor for"/>
 <result pre="of NOD miceMol Cell Endocrinol201642610111226911933 31.LiKWohlford-LenaneCLChannappanavarRParkJ-EEarnestJTBairTBBatesAMBrogdenKAFlahertyHAGallagherTMeyerholzDKPerlmanSMcCrayPBJrMouse-adapted MERS coronavirus causes lethal" exact="lung disease" post="in human DPP4 knockin miceProc Natl Acad Sci U"/>
 <result pre="NOD miceMol Cell Endocrinol201642610111226911933 31.LiKWohlford-LenaneCLChannappanavarRParkJ-EEarnestJTBairTBBatesAMBrogdenKAFlahertyHAGallagherTMeyerholzDKPerlmanSMcCrayPBJrMouse-adapted MERS coronavirus causes lethal lung" exact="disease" post="in human DPP4 knockin miceProc Natl Acad Sci U"/>
 <result pre="2020 Apr 9]; Available from: https://jamanetwork.com/journals/jama/fullarticle/2763667 35.Dietz W, Santos-Burgoa C." exact="Obesity" post="and its Implications for COVID-19 Mortality. Obesity [Internet]. 2020"/>
 <result pre="W, Santos-Burgoa C. Obesity and its Implications for COVID-19 Mortality." exact="Obesity" post="[Internet]. 2020 [cited 2020 Apr 9]; Available from: http://doi.wiley.com/10.1002/oby.22818"/>
 <result pre="Fang L, Xiaohui L, Tao W, Qikai W, et al." exact="Obesity" post="and COVID-19 Severity in a Designated Hospital in Shenzhen,"/>
 <result pre="V, Noulette J, Duhamel A, et al. High prevalence of" exact="obesity" post="in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive"/>
 <result pre="Duhamel A, et al. High prevalence of obesity in severe" exact="acute" post="respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation. Obesity"/>
 <result pre="A, et al. High prevalence of obesity in severe acute" exact="respiratory" post="syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation. Obesity [Internet]."/>
 <result pre="et al. High prevalence of obesity in severe acute respiratory" exact="syndrome" post="coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation. Obesity [Internet]. 2020"/>
 <result pre="severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation." exact="Obesity" post="[Internet]. 2020 [cited 2020 Apr 11]; Available from: http://doi.wiley.com/10.1002/oby.22831"/>
 <result pre="ill ICU patients with COVID-19. Thromb Res. 2020; 41.DhurandharNVBaileyDThomasDInteraction of" exact="obesity" post="and infections: interaction of obesity and infectionsObes Rev2015161017102926354800 42.Vieira-PotterVJInflammation"/>
 <result pre="Thromb Res. 2020; 41.DhurandharNVBaileyDThomasDInteraction of obesity and infections: interaction of" exact="obesity" post="and infectionsObes Rev2015161017102926354800 42.Vieira-PotterVJInflammation and macrophage modulation in adipose"/>
 <result pre="modulationCell Microbiol2014161484149225073615 43.MrazMHaluzikMThe role of adipose tissue immune cells in" exact="obesity" post="and low-grade inflammationJ Endocrinol2014222R113R12725006217 44.Sattar N, McInnes IB, McMurray"/>
 <result pre="and low-grade inflammationJ Endocrinol2014222R113R12725006217 44.Sattar N, McInnes IB, McMurray JJV." exact="Obesity" post="a risk factor for severe COVID-19 infection: multiple potential"/>
 <result pre="the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected" exact="pneumonia" post="(standard version)Mil Med Res20207432029004 48.GiustinaAAdlerRABinkleyNBouillonREbelingPRLazaretti-CastroMMarcocciCRizzoliRSemposCTBilezikianJPControversies in Vitamin D: summary"/>
 <result pre="and outstanding questionsEndocr Rev2019401109115130321335 50.MartineauARJolliffeDAHooperRLGreenbergLAloiaJFBergmanPet al.Vitamin D supplementation to prevent" exact="acute" post="respiratory tract infections: systematic review and meta-analysis of individual"/>
 <result pre="outstanding questionsEndocr Rev2019401109115130321335 50.MartineauARJolliffeDAHooperRLGreenbergLAloiaJFBergmanPet al.Vitamin D supplementation to prevent acute" exact="respiratory" post="tract infections: systematic review and meta-analysis of individual participant"/>
 <result pre="D play a role in the high impact of Covid" exact="infection" post="in Italy? BMJ march 202020 53.SemposCTHeijboerACBikleDDBollerslevJBouillonRBrannonPMDeLucaHFJonesGMunnsCFBilezikianJPGiustinaABinkleyNVitamin D assays and"/>
 <result pre="Liberman UA, Mazziotti G, Minisola S, et al. MANAGEMENT OF" exact="ENDOCRINE" post="DISEASE: therapeutics of vitamin D. Eur J Endocrinol. 2018:R239â€&quot;59."/>
 <result pre="outcome? [published online ahead of print, 2020 May 20]. Lancet" exact="Diabetes" post="Endocrinol. 2020;S2213â€&quot;8587(20)30183â€&quot;2. 10.1016/S2213-8587(20)30183-2 57.Rubel AR, Chong PL, Abdullah MS,"/>
 <result pre="Bradley P, Jennings J, Smith ZR. Letter to the Editor:" exact="Acute" post="hypertriglyceridemia in patients with COVID-19 receiving tocilizumab. J Med"/>
 <result pre="P, Jennings J, Smith ZR. Letter to the Editor: Acute" exact="hypertriglyceridemia" post="in patients with COVID-19 receiving tocilizumab. J Med Virol."/>
 <result pre="Taddei S, Vergaro G. Statin therapy in COVID-19 infection. Eur" exact="Heart" post="J - Cardiovasc Pharmacother. 2020;pvaa042. 62.ZeiserRImmune modulatory effects of"/>
 <result pre="and other immunomodulatory agentsAntivir Res20139941743523831494 64.LeowMK-SKwekDS-KNgAW-KOngK-CKawGJ-LLeeLS-UHypocortisolism in survivors of severe" exact="acute" post="respiratory syndrome (SARS)Clin Endocrinol200563197202 65.Pal R, Banerjee M. COVID-19"/>
 <result pre="other immunomodulatory agentsAntivir Res20139941743523831494 64.LeowMK-SKwekDS-KNgAW-KOngK-CKawGJ-LLeeLS-UHypocortisolism in survivors of severe acute" exact="respiratory" post="syndrome (SARS)Clin Endocrinol200563197202 65.Pal R, Banerjee M. COVID-19 and"/>
 <result pre="immunomodulatory agentsAntivir Res20139941743523831494 64.LeowMK-SKwekDS-KNgAW-KOngK-CKawGJ-LLeeLS-UHypocortisolism in survivors of severe acute respiratory" exact="syndrome" post="(SARS)Clin Endocrinol200563197202 65.Pal R, Banerjee M. COVID-19 and the"/>
 <result pre="clinical Spectrum of HypophysitisTrends Endocrinol Metab201930959060210.1016/j.tem.2019.06.00431345630 67.MelmedSBronsteinMDChansonPKlibanskiACasanuevaFFWassJAHStrasburgerCJLugerAClemmonsDRGiustinaAA consensus statement on" exact="acromegaly" post="therapeutic outcomesNat Rev Endocrinol201814955256110.1038/s41574-018-0058-530050156 68.Fleseriu M, Karavitaki N, Dekkers"/>
 <result pre="CrainMHoornEJSherlockMThompsonCJWassJAHEndocrinology in the time of COVID-19: management of Hyponatraemia and" exact="diabetes" post="InsipidusEur J Endocrinol2020183G9G1532380474 71.WeiLSunSXuC-HZhangJXuYZhuHPehSCKortewegCMcNuttMAGuJPathology of the thyroid in severe"/>
 <result pre="diabetes InsipidusEur J Endocrinol2020183G9G1532380474 71.WeiLSunSXuC-HZhangJXuYZhuHPehSCKortewegCMcNuttMAGuJPathology of the thyroid in severe" exact="acute" post="respiratory syndromeHum Pathol2007389510216996569 72.De JonghFEJÃ¶bsisACElteJWThyroid morphology in lethal non-thyroidal"/>
 <result pre="InsipidusEur J Endocrinol2020183G9G1532380474 71.WeiLSunSXuC-HZhangJXuYZhuHPehSCKortewegCMcNuttMAGuJPathology of the thyroid in severe acute" exact="respiratory" post="syndromeHum Pathol2007389510216996569 72.De JonghFEJÃ¶bsisACElteJWThyroid morphology in lethal non-thyroidal illness:"/>
 <result pre="the thyroid in severe acute respiratory syndromeHum Pathol2007389510216996569 72.De JonghFEJÃ¶bsisACElteJWThyroid" exact="morphology" post="in lethal non-thyroidal illness: a post-mortem studyEur J Endocrinol200114422122611248740"/>
 <result pre="in the time of COVID-19: Management of thyroid nodules and" exact="cancer" post="[published online ahead of print, 2020 May 1]. Eur"/>
 <result pre="nuclear medicine procedures in a high-prevalence regionJ Nucl Med202061563263610.2967/jnumed.120.24625632238429 75.BancosIHazeldineJChortisVHampsonPTaylorAELordJMArltWPrimary" exact="adrenal insufficiency" post="is associated with impaired natural killer cell function: a"/>
 <result pre="Simpson HL. Endocrinology in the time of COVID-19: management of" exact="adrenal insufficiency." post="Eur J Endocrinol. 2020. 77.WheatlandRMolecular mimicry of ACTH in"/>
 <result pre="for corticosteroid treatment and prophylaxisMed Hypotheses20046385586215488660 78.ArltW__. SOCIETY FOR ENDOCRINOLOGY" exact="ENDOCRINE" post="EMERGENCY GUIDANCE: Emergency management of acute adrenal insufficiency (adrenal"/>
 <result pre="78.ArltW__. SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Emergency management of" exact="acute" post="adrenal insufficiency (adrenal crisis) in adult patientsEndocr Connect20165G1G327935813 79.MazziottiGFormentiAMFraraSRocaEMortiniPBerrutiAGiustinaAMANAGEMENT"/>
 <result pre="SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Emergency management of acute" exact="adrenal insufficiency" post="(adrenal crisis) in adult patientsEndocr Connect20165G1G327935813 79.MazziottiGFormentiAMFraraSRocaEMortiniPBerrutiAGiustinaAMANAGEMENT OF ENDOCRINE"/>
 <result pre="GUIDANCE: Emergency management of acute adrenal insufficiency (adrenal crisis) in" exact="adult" post="patientsEndocr Connect20165G1G327935813 79.MazziottiGFormentiAMFraraSRocaEMortiniPBerrutiAGiustinaAMANAGEMENT OF ENDOCRINE DISEASE: risk of overtreatment"/>
 <result pre="adrenal insufficiency (adrenal crisis) in adult patientsEndocr Connect20165G1G327935813 79.MazziottiGFormentiAMFraraSRocaEMortiniPBerrutiAGiustinaAMANAGEMENT OF" exact="ENDOCRINE" post="DISEASE: risk of overtreatment in patients with adrenal insufficiency:"/>
 <result pre="MR, et al. Ca2+ ions promote fusion of Middle East" exact="respiratory" post="syndrome coronavirus with host cells and increase infectivity. J"/>
 <result pre="et al. Ca2+ ions promote fusion of Middle East respiratory" exact="syndrome" post="coronavirus with host cells and increase infectivity. J Virol."/>
 <result pre="in the greater Toronto areaJAMA.20032892801280912734147 86.UyekiTMMehtaAKDaveyRTLiddellAMWolfTVetterPet al.Clinical Management of Ebola" exact="Virus Disease" post="in the United States and EuropeN Engl J Med201637463664626886522"/>
 <result pre="the greater Toronto areaJAMA.20032892801280912734147 86.UyekiTMMehtaAKDaveyRTLiddellAMWolfTVetterPet al.Clinical Management of Ebola Virus" exact="Disease" post="in the United States and EuropeN Engl J Med201637463664626886522"/>
 <result pre="EuropeN Engl J Med201637463664626886522 87.Bossoni S, Chiesa L, Giustina A." exact="Severe" post="hypocalcemia in a thyroidectomized woman with Covid-19 infection. Endocrine"/>
 <result pre="Engl J Med201637463664626886522 87.Bossoni S, Chiesa L, Giustina A. Severe" exact="hypocalcemia" post="in a thyroidectomized woman with Covid-19 infection. Endocrine [Internet]."/>
 <result pre="Carlucci M Conte C, Ciceri F, Zangrillo A, Giustina A." exact="Hypocalcemia" post="is highly prevalent and predicts hospitalization in patients with"/>
 <result pre="and clinical characteristics of 99 cases of 2019 novel coronavirus" exact="pneumonia" post="in Wuhan, China: a descriptive studyLancet Lond Engl2020395507513 92.Channappanavar"/>
 <result pre="Ten Eyck PP, Meyerholz DK, Perlman S. Sex-Based Differences in" exact="Susceptibility to" post="Severe Acute Respiratory Syndrome Coronavirus Infection. J Immunol Baltim"/>
 <result pre="PP, Meyerholz DK, Perlman S. Sex-Based Differences in Susceptibility to" exact="Severe" post="Acute Respiratory Syndrome Coronavirus Infection. J Immunol Baltim Md"/>
 <result pre="Meyerholz DK, Perlman S. Sex-Based Differences in Susceptibility to Severe" exact="Acute" post="Respiratory Syndrome Coronavirus Infection. J Immunol Baltim Md 1950."/>
 <result pre="DK, Perlman S. Sex-Based Differences in Susceptibility to Severe Acute" exact="Respiratory" post="Syndrome Coronavirus Infection. J Immunol Baltim Md 1950. 2017;198:4046â€&quot;53."/>
 <result pre="Perlman S. Sex-Based Differences in Susceptibility to Severe Acute Respiratory" exact="Syndrome" post="Coronavirus Infection. J Immunol Baltim Md 1950. 2017;198:4046â€&quot;53. 93.HoffmannMKleine-WeberHSchroederSKrÃ¼gerNHerrlerTErichsenSSchiergensTSHerrlerGWuNHNitscheAMÃ¼llerMADrostenCPÃ¶hlmannSSARS-CoV-2"/>
 <result pre="protease TMPRSS2 activates a proteolytic cascade involving components of the" exact="tumor" post="microenvironment and promotes prostate cancer metastasisCancer Discov201441310132525122198 95.TomlinsSARecurrent fusion"/>
 <result pre="proteolytic cascade involving components of the tumor microenvironment and promotes" exact="prostate cancer" post="metastasisCancer Discov201441310132525122198 95.TomlinsSARecurrent fusion of TMPRSS2 and ETS transcription"/>
 <result pre="cascade involving components of the tumor microenvironment and promotes prostate" exact="cancer" post="metastasisCancer Discov201441310132525122198 95.TomlinsSARecurrent fusion of TMPRSS2 and ETS transcription"/>
 <result pre="Kantoff PW. TMPRSS2 and COVID-19: Serendipity or Opportunity for Intervention?" exact="Cancer" post="Discov. 2020;candisc;2159â€&quot;8290.CD-20-0451v3. 97.Hanff TC, Harhay MO, Brown TS, Cohen"/>
 <result pre="receptor blockers on cardiac angiotensin-converting enzyme 2Circulation.20051112605261015897343 101.FangLKarakiulakisGRothMAre patients with" exact="hypertension" post="and diabetes mellitus at increased risk for COVID-19 infection?Lancet"/>
 <result pre="on cardiac angiotensin-converting enzyme 2Circulation.20051112605261015897343 101.FangLKarakiulakisGRothMAre patients with hypertension and" exact="diabetes mellitus" post="at increased risk for COVID-19 infection?Lancet Respir Med20208e2132171062 102.VaduganathanMVardenyOMichelTMcMurrayJJVPfefferMASolomonSDReninâ€&quot;angiotensinâ€&quot;aldosterone"/>
 <result pre="Med20203821653165932227760 103.Sommerstein R, Kochen MM, Messerli FH, GrÃ¤ni C. Coronavirus" exact="Disease" post="2019 (COVID-19): Do Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have"/>
 <result pre="Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect? J Am" exact="Heart" post="Assoc [Internet]. 2020 [cited 2020 May 21];9. Available from:"/>
</results>
